Summary: Interbody fusion cages are routinely implanted during spinal fusion procedures to facilitate arthrodesis of a degenerated or unstable vertebral segment. Current cages are most commonly made from polyether-ether-ketone (PEEK) due to its favorable mechanical properties and imaging characteristics. However, the smooth surface of current PEEK cages may limit implant osseointegration and may inhibit successful fusion. We present the development and clinical application of the first commercially available porous PEEK fusion cage (COHERE s) that aims to enhance PEEK osseointegration and spinal fusion outcomes. The porous PEEK structure is extruded directly from the underlying solid and mimics the structural and mechanical properties of trabecular bone to support bone ingrowth and implant fixation. Biomechanical testing of the COHERE device has demonstrated greater expulsion resistance versus smooth PEEK cages with ridges and greater adhesion strength of porous PEEK versus plasma-sprayed titanium coated PEEK surfaces. In vitro experiments have shown favorable cell attachment to porous PEEK and greater proliferation and mineralization of cell cultures grown on porous PEEK versus smooth PEEK and smooth titanium surfaces, suggesting that the porous structure enhances bone formation at the cellular level. At the implant level, preclinical animal studies have found comparable bone ingrowth into porous PEEK as those previously reported for porous titanium, leading to twice the fixation strength of smooth PEEK implants. Finally, two clinical case studies are presented demonstrating the effectiveness of the COHERE device in cervical spinal fusion.
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HISTORY OF POLYETHER-ETHER-KETONE (PEEK) IN SPINE
In 2014 in the United States, spinal fusion was performed in 415,000 patients, making fusion surgery the third most common orthopaedic procedure behind hip and knee arthroplasty. 1, 2 Spinal fusion procedures utilize neural decompression and arthrodesis to reduce pain and vertebral segment motion associated with spinal degeneration, instability, deformity, and trauma. 3, 4 First investigated in the late 1950s, interbody spinal fusion using autograft bone, allograft bone, or a synthetic interbody fusion device (IBD, or more commonly referred to as a "cage") to facilitate fusion across the intervertebral disk space has now become a routine procedure. 5 Nevertheless, the design and composition of fusion cages continues to evolve as technologies are developed that better meet patient and surgeon needs.
The majority of current synthetic cages are made from PEEK polymer. First introduced in the 1990s, PEEK has gained widespread acceptance in spine and orthopaedics due to its imaging characteristics, high strength, fatigue resistance, and Young's modulus that is comparable with bone to reduce stress-shielding. 6 Although PEEK's mechanical and imaging properties have contributed to its popularity, recent reports have demonstrated that conventional smooth PEEK implants can exhibit poor osseointegration and fibrous encapsulation. [6] [7] [8] [9] Outcomes from previous studies support that these effects result from the implant surface being smooth because both smooth PEEK and smooth titanium exhibit similarly low-bone fixation compared with rough and porous surfaces. 10, 11 However, PEEK's poor osseointegration is often, without direct evidence, "attributed" to other properties, such as its relatively inert and hydrophobic surface chemistry. 10, 12, 13 As a result, multiple efforts to modify PEEK implants' surface composition and improve osseointegration have been made, such as plasma-sprayed titanium coatings on PEEK (TiPEEK) and PEEK-hydroxyapatite composites. However, many of these technologies have exhibited only modest improvements in osseointegration and may suffer practical limitations to their adoption such as: potential delamination, instability, and mechanical property tradeoffs, suggesting the need to develop alternative solutions. [14] [15] [16] [17] [18] [19] 
EFFECTS OF SURFACE STRUCTURE
Although PEEK's hydrophobicity may play a role, extensive research on non-PEEK materials, particularly titanium, suggests that surface topography (or structure) would have a first-order impact on PEEK's ability to osseointegrate. Although compositionally different, research on titanium may inform analogous investigations on PEEK, which are sparse. Surface structures on orthopaedic implants can largely be divided into 2-dimensional (2D) textured surfaces and 3-dimensional (3D) porous networks. Most 2D textured surfaces possess microscale roughness (S a = 1 to 2 μm) that mimics osteoclast resorption pits and is generally associated with a beneficial bone response. 20, 21 For reprint requests, or additional information and guidance on the techniques described in the article, please contact Kathryn E. Smith, as well understood, [21] [22] [23] [24] and other characteristics such as surface chemistry may have a stronger effect. 25 In contrast to 2D surfaces, 3D surfaces are typically characterized by an interconnected porous network (100 to 800 μm pores) to facilitate bone ingrowth and provide mechanical interlock at the boneimplant interface. [26] [27] [28] Although 2D and 3D surface structures have been shown to improve osseointegration when evaluated in isolation, recent studies have begun to investigate the combined effects of multiscale surface features on cellular behavior and implant osseointegration. Such strategies are useful in determining the relative effects of surface features at each length scale. Notably, studies on titanium have reported that nanoscale surfaces contributed relatively little to bone cell behavior in the absence of larger microscale features. 29, 30 Similarly, microtextured surfaces seem to contribute less to implant osseointegration compared with 3D macroporosity. 11, 31 Taken as a whole, the titanium surface literature suggests that 3D macroscale porosity is the dominant surface structure influencing implant osseointegration.
Although the above conclusions are drawn from reports on titanium, we hypothesize that similar concepts hold true for PEEK. Initial reports of bone ingrowth into porous PEEK implants supported this view, yet, until now, porous PEEK technologies in the literature had yet to reach clinical use and remained at various stages of development (Table 1) . 13, [32] [33] [34] [35] [36] [37] [38] [39] Herein, we describe a new porous PEEK biomaterial with similar physical and mechanical properties of standard PEEK that is able to osseointegrate without the typical fibrous tissue response associated with current smooth PEEK implants. We then demonstrate its application on a novel IBD and successful clinical use in anterior cervical discectomy and fusion (ACDF) surgery ( Fig. 1 ).
POROUS PEEK DEVELOPMENT Structural and Mechanical Properties
Designed to mimic the 3D structure of human trabecular bone, the porous PEEK biomaterial was created using a proprietary process that extrudes the porous architecture directly from the underlying bulk PEEK material. 34 Micro-computed tomography (μCT) analysis has demonstrated porous PEEK to have an average strut spacing of 169 to 248 μm, strut thickness of 73 to 119 μm, and porosity of 67% to 75% 34, 35, 37 (Table 2) . Corresponding μCT analysis of human trabecular bone has reported similar microstructural properties as those possessed by porous PEEK 42 (Table 2) .
Due to the complex loading environment within the spine, it is imperative that the porous PEEK maintains its structural integrity under physiological forces. Prior research has investigated porous PEEK's ability to tolerate vertebral compressive loads without failure. 37 When isolated, the porous PEEK structure exhibited a compressive yield strength of 8 to 11 MPa and compressive modulus of 90 to 110 MPa, both ranges being of similar magnitude to vertebral trabecular bone properties. 26, 41 For a clinical comparison, typical loading in the lumbar spine ranges from 1000 to 3000 N. 43, 44 Thus,~115 to 350 mm 2 of load bearing cage area would be required to keep the porous PEEK architecture below its compressive yield strength. Detailed microstructural and mechanical 36 Evans et al 37 Siddiq et al 38 •
•
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• •
The Web of Science database was searched for "TITLE: (porous OR scaffold OR three-dimensional OR 3D) AND (PEEK OR polyether ether ketone OR polyether-ether-ketone OR polyetheretherketone)" with no date restrictions on November 6, 2016. In all, 40 results were found. In total, 34 results were excluded based on: nonmedical focus; theoretical models; porous PEEK composites; non-PEEK materials; and nonporous materials. Three articles were added from the authors' library.
FDA indicates Food and Drug Administration; PEEK, polyether-ether-ketone. properties of bone and porous PEEK are summarized in Table 2 . 26, [34] [35] 37, 40, 41, 42 To evaluate the pore deformation that could result in cases of extreme compressive loading in the spine, porous samples were imaged at increasing strain levels (5% to 70%) using a compression device combined with μCT imaging (n = 3, μCT50; Scanco Medical). 37 As expected, percent porosity decreased with increasing strain. However, even at supraphysiological compressive stresses upwards of 15 to 20 MPa, the porous architecture maintained~70% of its initial porosity that would be available for bone ingrowth (Fig. 2) . 37 Besides its compressive properties, porous PEEK has also been evaluated under shear fatigue and compared with TiPEEK as another clinically relevant PEEK modification. Shear fatigue testing followed ASTM F1160-05 to determine fatigue life of porous PEEK compared with TiPEEK (APS Materials, Dayton, OH). Cylindrical samples (d = 20 mm) were adhered with epoxy and tested in shear on a MTS Satec servohydraulic test frame at 8.1 MPa at 40 Hz with R = 0.18 (n = 3). The test ended when the specimen failed or a runout of 10 7 cycles was achieved. The TiPEEK samples failed at an average of 2,622,000 cycles, whereas all porous PEEK samples achieved runout of > 10,000,000 cycles. The chosen shear fatigue stress level of 8 MPa is greater than the shear strength of trabecular bone (5 to 7 MPa), 45, 46 which suggests that porous PEEK can survive physiological shear loads, whereas the plasma-sprayed titanium coating may not be able to survive the same physiological shear loading conditions. However, clinical evidence of plasmasprayed titanium coating failure remains anecdotal 47 and has yet to be published in the peer-reviewed literature.
Biological Properties
The biological performance of porous PEEK has been evaluated using a range of in vitro and in vivo models. In vitro results continue to support porous PEEK's ability to facilitate cell attachment, proliferation and osteogenic differentiation of multiple bone cell lineages. 35 Live/dead imaging of clonal mouse preosteoblast cells (MC3T3-E1, ATCC) seeded at 20,000 cells/cm 2 and cultured in growth media (α-minimum essential media supplemented with 16.7% fetal bovine serum and 1% penicillin-streptomycin-L-glutamine) revealed cell attachment to the porous PEEK architecture at day 0 and thorough cell layer coverage of the pores by day 14, demonstrating favorable cell growth and proliferation on porous PEEK (Fig. 3) . Cell proliferation on porous PEEK was further investigated by quantifying the incorporation of 5-ethynyl-2′-deoxyuridine into the DNA of human mesenchymal stem cell (hMSC) and human osteoblast cultures in growth media. 35 Both hMSC and human osteoblast cultures exhibited increased proliferation on porous PEEK compared with smooth PEEK, smooth Ti6Al4V and tissue culture treated polystyrene 48 hours after seeding (Fig. 4) . This early proliferative phase is thought to generate extracellular matrix proteins that facilitate subsequent matrix mineralization. 48 Indeed, hMSC cultures exhibited extensive mineralization as evidenced by Alizarin red staining of porous PEEK cultures grown in osteogenic media for 4 weeks (Fig. 5) . Enhanced cell-mediated mineralization of porous PEEK was further confirmed by quantifying the calcium content of in vitro cultures grown in osteogenic media for 14 days and comparing against smooth PEEK, smooth Ti6Al4V and tissue culture treated polystyrene (Fig. 6) . These results are consistent with previous studies on roughened and porous titanium surfaces and suggest porous PEEK can enhance mineralization at the cellular level. 30, 49 Results from preclinical animal models have reinforced in vitro results on porous PEEK by demonstrating its ability to support bone tissue ingrowth and implant fixation. Porous PEEK implants have undergone preliminary in vivo evaluation in a proximal tibial plug model 49 (n = 4 to 5) and femoral segmental defect (n = 6) model of the rat, 50 both exhibiting similar results. 50, 51 μCT imaging demonstrated that 40% ± 14% of the available pore space on tibial implants contained mineralized tissue at 8 weeks (Fig. 7) . This degree of bone ingrowth into porous PEEK is comparable with that previously reported for porous titanium implants. 52 Biomechanical pullout testing of tibial implants demonstrated that porous-faced PEEK implants exhibited over twice the integration strength of smooth PEEK implants (40.0 ± 5.4 N vs. 17.9 ± 4.6 N; p < 0.01-Student t test) (Fig. 7) . Nondecalcified histologic sections from segmental defect samples confirmed that the mineralized tissue within the porous region was bone using a Goldner Trichrome stain (Fig. 8) . These results indicate that introducing porosity into PEEK can improve PEEK's osseointegration. 
COHERE CERVICAL FUSION DEVICE Device Design
Given the mechanical and biological performance established in preclinical testing, a new IBD incorporating porous PEEK (COHEREs; Vertera Spine, Atlanta, GA) has been developed for use in ACDF procedures. The implant is manufactured out of a solid PEEK core with the porous PEEK architecture on the superior and inferior faces (Fig. 1) . This design allows for bony tissue ingrowth from adjacent vertebra while retaining the bulk physical and mechanical properties of PEEK for device structural integrity. The porous architecture also aids in creating more frictional resistance against bone, thereby reducing the risk for expulsion. Like other PEEK devices, the COHERE device is radiolucent and does not produce imaging artifacts on x-ray and CT, a characteristic observed in the preclinical testing of porous PEEK (Fig. 7) . The device also features a large graft window, a 7 degree lordotic angle, and radiographic markers that run through the entire device on opposite ends.
Biomechanical Testing
The porous PEEK device has been subjected to extensive biomechanical testing to evaluate its durability and frictional properties under clinically relevant loading scenarios as part of its Food and Drug Administration 510(k) submission. Tensile adhesion strength testing was performed to determine the adhesive strength of the porous architecture to the solid PEEK base and compared with TiPEEK devices (Calix PC; X-Spine Systems Inc., Miamisburg, OH). Following ASTM F1147-05, porous PEEK devices and TiPEEK devices were mounted with epoxy and pulled in tension at 0.25 cm/min with a mechanical test frame (Instron) until the components separated. Tensile adhesion strength was defined as the failure load normalized by the load-bearing cross-sectional area (n = 4 to 5). Porous PEEK devices had a higher tensile adhesion strength than TiPEEK devices (13.7 ± 0.6 vs. 7.7 ± 3.6 MPa; p < 0.01-Student t test), which supports that porous PEEK is more durable than TiPEEK. Notably these values are less than the tensile adhesion strength reported for standard flat 20-mm-diameter adhesion cylinders (Porous PEEK: 24.7 ± 0.6 MPa, TiPEEK: 19.3 ± 2.1 MPa). This difference is attributed to the increased edge-to-surface ratio of these fusion devices (0.7 to 1.0/mm) compared with the cylindrical test samples (0.2/mm).
Next, porous PEEK devices were subjected to implant push-out testing in a benchtop intervertebral model to investigate their resistance to expulsion. Each device was inserted in between two polyurethane foam blocks (Sawbone, 15 PCF) and a 157 N normal force was applied to the blocks to simulate axial compression of the cervical spine. A transverse load was then applied to the posterior implant face at a rate of 0.1 mm/s until the implant expulsed. Throughout the design of the COHERE device it was determined that, in contrast to smooth devices, adding ridges to the porous faces of the implant did not improve expulsion resistance (Fig. 9) . Thus, COHERE devices feature flat porous faces to provide maximum contact area between bone and porous architecture upon implantation. To ensure adequate expulsion resistance, the final COHERE device was compared with a clinically available smooth PEEK cage that uses ridges (Crystal Cervical Interbody System; Spinal Elements, Carlsbad, CA) and the COHERE device was found to have 71% greater expulsion force (466 ± 31 vs. 271 ± 49 N; p < 0.01-Student t test, n = 5).
Surgical Technique
The COHERE device can be implanted into the intervertebral disk space using a standard ACDF surgical technique similar to that used for implanting other cervical cages. The affected disk and adjacent vertebral bodies are exposed via an anterior approach. Once a discectomy is performed per standard procedure and the segment distracted, the endplates can be prepared using rasps, curettes, and/or other instruments of choice. Implant trials matching the footprint and height of each implant size offering are used to determine the appropriate COHERE implant size. We have found the trial size (footprint×height) accurately matches the same implant footprint and height. Once the appropriate implant size is selected, the interior window of the COHERE cage is then packed with bone graft and placed anteriorly into the disk space using a universal inserter. Of note, one of the authors has described using the high friction porous faces in a rasp-like manner to collect additional autograft from the endplates within the pores to provide an improved healing bed for fusion. Implant location can be verified on fluoroscopy as needed. If further adjustment is needed, a tamp can be used to accurately position the cage into place. Lastly, additional bone graft material can then be packed around the cage, if desired. Usually immediately after implantation, bleeding bone can be seen wicking into the porous architecture on the cage (Fig. 10) .
Clinical Examples
To date, the clinical authors have performed over 100 ACDF surgeries using the COHERE device with no devicerelated complications reported up to 1 year post-operatively. Here, two case examples are described where the COHERE implant was used to first surgically treat a previously failed fusion surgery and then used in a multi-level surgery.
Case Example 1
A 64-year-old woman, who had undergone two previous cervical fusions in 1982 and 1997, developed adjacent segment degeneration at the C3-C4 cervical level. The patient reported neck pain and arm radiculopathy and had objective neurological signs of weakness, loss of sensation and depressed reflexes. A lateral radiograph showed disk space collapse, radial osteophyte formation, and sagittal plane malalignment (retrolisthesis and kyphosis) at the C3-C4 level (Fig. 11A) .
The patient underwent an ACDF and received a porous PEEK COHERE implant in conjunction with an anterior plate and autogenous iliac crest taken through a minimally invasive approach using only cancellous bone and bone marrow aspirate. At 3 months after surgery, a lateral radiograph showed restoration and maintenance of anatomic disk space height, segmental lordosis, and normal sagittal alignment (Fig. 11B) . The patient had excellent relief of neck pain and radiating pain with complete return of neurological status. After surgery and follow-up she was neurologically intact. Importantly, there were no lucencies around the PEEK implant. An uninterrupted, continuous column of bone was seen through the central portion of the COHERE implant with complete integration of the bone graft to the bony endplates of the adjacent vertebra. 
Case Example 2
A 55-year-old woman with a history of diabetes type 2 and body mass index > 50 presented for evaluation and management after having had a previous multi-level ACDF (C4-C6) with an outside surgeon~7 years before. The patient presented with persistent neck pain of 7/10 on the pain scale, with 100% neck pain. The patient was ordered to undergo an electromyography and CTmyelogram. The electromyography of the upper extremities was unremarkable. The cervical spine CT-myelogram revealed a disc osteophyte complex at C6-C7 cervical level with pseudarthrosis at C5-C6 level (Fig. 12A) .
After a year of unsuccessful conservative treatment, the patient underwent surgery for revision ACDF using the porous FIGURE 9 . A, Expulsion forces of smooth and porous polyetherether-ketone devices with and without ridges. All data normalized to smooth cages without ridges. *p < 0.01,^p < 0.01 versus other smooth groups (2-way Analysis of Variance, Tukey) (mean ± SE). B, Images depicting cage and ridge geometries. Scale bar is 1 cm. FIGURE 10. Intraoperative photo showing a porous polyetherether-ketone device implanted in an anterior cervical discectomy and fusion surgery. Soon after insertion into the disk space, blood could be seen wicking into the porous architecture. PEEK COHERE implant for painful pseudoarthrosis at C5-C6 with microscopic anterior discectomy and decompression of spinal canal stenosis as well as bilateral neuroforaminotomies at C6-C7, with extension of fusion at C6-C7 (Fig. 12B) . Demineralized bone matrix was used as allograft to fill the interior window of the cage along with plates and screws to provide segmental stabilization.
At 5 months after surgery, the patient was seen for follow-up. Anterior-posterior and lateral radiographs were completed showing the COHERE implant, plate, and screws intact and in good position with solid-appearing interosseous growth at C5-C6 and C6-C7. It was noted that disk height had improved and lordosis had been restored and maintained. The patient reported functional range of motion in all planes of the cervical spine and presented a postoperative pain score of 0/10. The patient had discontinued all opiate use 4 months postoperatively.
CONCLUSIONS
Preliminary clinical and preclinical results suggest that the COHERE interbody fusion device featuring porous PEEK can support spinal fusion and may offer improved osseointegration compared with conventional smooth PEEK. The method of extruding the pores from the underlying solid imparts unique mechanical properties that support porous PEEK's ability to bear physiological loads without crushing or delamination. Future studies are focused on evaluating long-term clinical outcomes to assess the efficacy and stability of the COHERE device.
